222 related articles for article (PubMed ID: 30903741)
21. A Novel Irreversible TEAD Inhibitor, SWTX-143, Blocks Hippo Pathway Transcriptional Output and Causes Tumor Regression in Preclinical Mesothelioma Models.
Hillen H; Candi A; Vanderhoydonck B; Kowalczyk W; Sansores-Garcia L; Kesikiadou EC; Van Huffel L; Spiessens L; Nijs M; Soons E; Haeck W; Klaassen H; Smets W; Spieser SA; Marchand A; Chaltin P; Ciesielski F; Debaene F; Chen L; Kamal A; Gwaltney SL; Versele M; Halder GA
Mol Cancer Ther; 2024 Jan; 23(1):3-13. PubMed ID: 37748190
[TBL] [Abstract][Full Text] [Related]
22. Structural and ligand-binding analysis of the YAP-binding domain of transcription factor TEAD4.
Li Y; Liu S; Ng EY; Li R; Poulsen A; Hill J; Pobbati AV; Hung AW; Hong W; Keller TH; Kang C
Biochem J; 2018 Jun; 475(12):2043-2055. PubMed ID: 29760238
[TBL] [Abstract][Full Text] [Related]
23. An Early Association between the α-Helix of the TEAD Binding Domain of YAP and TEAD Drives the Formation of the YAP:TEAD Complex.
Bokhovchuk F; Mesrouze Y; Meyerhofer M; Zimmermann C; Fontana P; Erdmann D; Jemth P; Chène P
Biochemistry; 2020 May; 59(19):1804-1812. PubMed ID: 32329346
[TBL] [Abstract][Full Text] [Related]
24. Regulation of the Hippo Pathway Transcription Factor TEAD.
Lin KC; Park HW; Guan KL
Trends Biochem Sci; 2017 Nov; 42(11):862-872. PubMed ID: 28964625
[TBL] [Abstract][Full Text] [Related]
25. Hippo pathway inhibition by blocking the YAP/TAZ-TEAD interface: a patent review.
Crawford JJ; Bronner SM; Zbieg JR
Expert Opin Ther Pat; 2018 Dec; 28(12):867-873. PubMed ID: 30482112
[No Abstract] [Full Text] [Related]
26. A transcriptional cofactor YAP regulates IFNT expression via transcription factor TEAD in bovine conceptuses.
Kusama K; Bai R; Sakurai T; Bai H; Ideta A; Aoyagi Y; Imakawa K
Domest Anim Endocrinol; 2016 Oct; 57():21-30. PubMed ID: 27315596
[TBL] [Abstract][Full Text] [Related]
27. YAP/TAZ-TEAD signalling axis: A new therapeutic target in malignant pleural mesothelioma.
Papavassiliou KA; Sofianidi AA; Papavassiliou AG
J Cell Mol Med; 2024 Apr; 28(8):e18330. PubMed ID: 38606782
[TBL] [Abstract][Full Text] [Related]
28. Adaptation of the bound intrinsically disordered protein YAP to mutations at the YAP:TEAD interface.
Mesrouze Y; Bokhovchuk F; Izaac A; Meyerhofer M; Zimmermann C; Fontana P; Schmelzle T; Erdmann D; Furet P; Kallen J; Chène P
Protein Sci; 2018 Oct; 27(10):1810-1820. PubMed ID: 30058229
[TBL] [Abstract][Full Text] [Related]
29. Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation.
Lin KC; Moroishi T; Meng Z; Jeong HS; Plouffe SW; Sekido Y; Han J; Park HW; Guan KL
Nat Cell Biol; 2017 Jul; 19(8):996-1002. PubMed ID: 28752853
[TBL] [Abstract][Full Text] [Related]
30. Targeting Transcriptional Enhanced Associate Domains (TEADs).
Gibault F; Sturbaut M; Bailly F; Melnyk P; Cotelle P
J Med Chem; 2018 Jun; 61(12):5057-5072. PubMed ID: 29251924
[TBL] [Abstract][Full Text] [Related]
31. Identification of FAM181A and FAM181B as new interactors with the TEAD transcription factors.
Bokhovchuk F; Mesrouze Y; Delaunay C; Martin T; Villard F; Meyerhofer M; Fontana P; Zimmermann C; Erdmann D; Furet P; Scheufler C; Schmelzle T; Chène P
Protein Sci; 2020 Feb; 29(2):509-520. PubMed ID: 31697419
[TBL] [Abstract][Full Text] [Related]
32. Structural and functional analysis of the YAP-binding domain of human TEAD2.
Tian W; Yu J; Tomchick DR; Pan D; Luo X
Proc Natl Acad Sci U S A; 2010 Apr; 107(16):7293-8. PubMed ID: 20368466
[TBL] [Abstract][Full Text] [Related]
33. Blockage of glioma cell survival by truncated TEAD-binding domain of YAP.
Zhao W; Dong QF; Li LW; Yan ZF; Huo JL; Chen XY; Yang X; Li PQ; Fei Z; Zhen HN
J Cancer Res Clin Oncol; 2021 Jun; 147(6):1713-1723. PubMed ID: 33651140
[TBL] [Abstract][Full Text] [Related]
34. Fluorescence polarization assay for the identification and evaluation of inhibitors at YAP-TEAD protein-protein interface 3.
Zhou W; Li Y; Song J; Li C
Anal Biochem; 2019 Dec; 586():113413. PubMed ID: 31479631
[TBL] [Abstract][Full Text] [Related]
35. A new perspective on the interaction between the Vg/VGLL1-3 proteins and the TEAD transcription factors.
Mesrouze Y; Aguilar G; Bokhovchuk F; Martin T; Delaunay C; Villard F; Meyerhofer M; Zimmermann C; Fontana P; Wille R; Vorherr T; Erdmann D; Furet P; Scheufler C; Schmelzle T; Affolter M; Chène P
Sci Rep; 2020 Oct; 10(1):17442. PubMed ID: 33060790
[TBL] [Abstract][Full Text] [Related]
36. Targeting the Central Pocket in Human Transcription Factor TEAD as a Potential Cancer Therapeutic Strategy.
Pobbati AV; Han X; Hung AW; Weiguang S; Huda N; Chen GY; Kang C; Chia CS; Luo X; Hong W; Poulsen A
Structure; 2015 Nov; 23(11):2076-86. PubMed ID: 26592798
[TBL] [Abstract][Full Text] [Related]
37. Yap/Taz-TEAD activity links mechanical cues to progenitor cell behavior during zebrafish hindbrain segmentation.
Voltes A; Hevia CF; Engel-Pizcueta C; Dingare C; Calzolari S; Terriente J; Norden C; Lecaudey V; Pujades C
Development; 2019 Jul; 146(14):. PubMed ID: 31273051
[TBL] [Abstract][Full Text] [Related]
38. Leveraging Hot Spots of TEAD-Coregulator Interactions in the Design of Direct Small Molecule Protein-Protein Interaction Disruptors Targeting Hippo Pathway Signaling.
Zhao B; Pobbati AV; Rubin BP; Stauffer S
Pharmaceuticals (Basel); 2023 Apr; 16(4):. PubMed ID: 37111340
[TBL] [Abstract][Full Text] [Related]
39. VGLL2 and TEAD1 fusion proteins drive YAP/TAZ-independent transcription and tumorigenesis by engaging p300.
Guo S; Hu X; Cotton JL; Ma L; Li Q; Cui J; Wang Y; Thakare RP; Tao Z; Ip YT; Wu X; Wang J; Mao J
bioRxiv; 2024 May; ():. PubMed ID: 38746415
[TBL] [Abstract][Full Text] [Related]
40. Targeting YAP/TAZ-TEAD protein-protein interactions using fragment-based and computational modeling approaches.
Kaan HYK; Sim AYL; Tan SKJ; Verma C; Song H
PLoS One; 2017; 12(6):e0178381. PubMed ID: 28570566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
